Yumanity Therapeutics Inc
Change company Symbol lookup
Select an option...
YMTX Yumanity Therapeutics Inc
FIVN Five9 Inc
IPOF Social Capital Hedosophia Holdings Corp VI
NIO NIO Inc
NRT North European Oil Royalty Trust
JNJ Johnson & Johnson
STAG STAG Industrial Inc
TM Toyota Motor Corp
HSIC Henry Schein Inc
VIVC Vivic Corp
Go

Company profile

Yumanity Therapeutics Inc, formerly Proteostasis Therapeutics, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in treatment of neurodegenerative diseases through its scientific foundation and drug discovery platform. The platform is designed to enable the Company to screen for potential disease-modifying therapies by overcoming toxicity of misfolded proteins in neurogenerative diseases. The Company's product candidate, YTX-7739, is in Phase 1 clinical development for Parkinson's disease and YTX-9184, in IND-enabling studies for Dementia with Lewy Bodies. The Company’s pipeline consists of additional programs focused on multi- system atrophy, amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), frontotemporal lobar dementia (FTLD), and Alzheimer's disease.

The symbol you entered, PTI, changed to YMTX.

Price
Delayed
$20.26
Day's Change
0.09 (0.45%)
Bid
--
Ask
--
B/A Size
--
Day's High
20.39
Day's Low
19.13
Volume
(Below Average)

Today's volume of 26,988 shares is on pace to be lower than YMTX's 10-day average volume of 62,854 shares.

26,988
  • Prev Close
    20.17
  • Today's Open
    20.19
  • Day's Range
    19.13-20.39
  • Avg Vol (10-day)
    62.9K
  • Last (time)
    12:39p ET 01/26/21
  • Last (size)
    25
  • 52-Wk Range
    16.27 - 44.00
    LowHigh
  • (02/21/20 - 12/28/20)
    24.52%
  • 88.9%
  • Market Cap
    204.5M
  • Shares Outstanding
    10.1M
  • -14.95
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.1
  • 25.17
  • (% of float 12/31/20)
    0.21

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.